Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,219 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,151
Recruiting: 2,255
Ph III recruiting: 266
Growth YoY: +13.3%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,892)

clinicaltrialsPublishedShowing 1–50 of 221 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06084234	National Liver Cancer Screening Trial(TRACER)	recruiting	Phase 4	5,500	University of Texas Southwestern Medical CenterOTHER	1	Sep 25, 2026	clinicaltrials
NCT05252585	A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)	active not recruiting	Phase 4	4	Novartis PharmaceuticalsINDUSTRY	1	Sep 17, 2026